Journal
THERANOSTICS
Volume 11, Issue 3, Pages 1377-1395Publisher
IVYSPRING INT PUBL
DOI: 10.7150/thno.52442
Keywords
arachidonic acid; phosphoproteomics; macropinocytosis; ovarian cancer
Categories
Funding
- Wilhelm Sander Stiftung [2016.123.1]
- Fundacion Ramon Areces
- German Academic Exchange Service (DAAD)
Ask authors/readers for more resources
The study reveals a potential link between arachidonic acid (AA) and macrophage functions in the ovarian cancer microenvironment. The signaling pathways triggered by non-metabolized AA involve the ASK1 - p38 delta/alpha axis, leading to impaired actin filament organization, inhibition of macropinocytosis, and enhanced release of exosome-like vesicles. The enzyme PLA2G2A is identified as a potential prognostic tool and therapeutic target in interfering with OC progression.
Arachidonic acid (AA) is a polyunsaturated fatty acid present at high concentrations in the ovarian cancer (OC) microenvironment and associated with a poor clinical outcome. In the present study, we have unraveled a potential link between AA and macrophage functions. Methods: AA-triggered signal transduction was studied in primary monocyte-derived macrophages (MDMs) by phosphoproteomics, transcriptional profiling, measurement of intracellular Ca2+ accumulation and reactive oxygen species production in conjunction with bioinformatic analyses. Functional effects were investigated by actin filament staining, quantification of macropinocytosis and analysis of extracellular vesicle release. Results: We identified the ASK1 - p38 delta/alpha (MAPK13/14) axis as a central constituent of signal transduction pathways triggered by non-metabolized AA. This pathway was induced by the Ca2+-triggered activation of calmodulin kinase II, and to a minor extent by ROS generation in a subset of donors. Activated p38 in turn was linked to a transcriptional stress response associated with a poor relapse-free survival. Consistent with the phosphorylation of the p38 substrate HSP27 and the (de)phosphorylation of multiple regulators of Rho family GTPases, AA impaired actin filament organization and inhibited actin-driven macropinocytosis. AA also affected the phosphorylation of proteins regulating vesicle biogenesis, and consistently, AA enhanced the release of tetraspanin-containing exosome-like vesicles. Finally, we identified phospholipase A2 group 2A (PLA2G2A) as the clinically most relevant enzyme producing extracellular AA, providing further potentially theranostic options. Conclusion: Our results suggest that AA contributes to an unfavorable clinical outcome of OC by impacting the phenotype of tumor-associated macrophages. Besides critical AA-regulated signal transduction proteins identified in the present study, PLA2G2A might represent a potential prognostic tool and therapeutic target to interfere with OC progression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available